Sage Therapeutics

YTD

ALL

Why Robinhood?

You can watch SAGE and buy or sell other stocks, ETFs, and their options commission-free!

About SAGE

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain.

CEO

Barry E. Greene, MD

CEOBarry E. Greene, MD

Employees

353

Employees353

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

353

Employees353

SAGE Key Statistics

Market cap

543.61M

Market cap543.61M

Price-Earnings ratio

-1.77

Price-Earnings ratio-1.77

Dividend yield

—

Dividend yield—

Average volume

3.47M

Average volume3.47M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$9.36

52 Week high$9.36

52 Week low

$4.62

52 Week low$4.62

People also own

Based on the portfolios of people who own SAGE. This list is generated using Robinhood data, and it’s not a recommendation.